Published May 12, 2021 | Version v1
Journal article Open

Serotonergic gene-to-gene interaction is associated with mood and GABA concentrations but not with pain-related cerebral processing in fibromyalgia subjects and healthy controls

  • 1. Department of Clinical Neuroscience, Karolinska Insitutet, Nobels väg 9, 17177, Stockholm, Sweden
  • 2. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden
  • 3. MRI Research Center, Karolinska University Hospital, Stockholm, Sweden

Description

The neurotransmitter serotonin, involved in the regulation of pain and emotion, is critically regulated by the 5‐HT1A autoreceptor and the serotonin transporter (5-HTT). Polymorphisms of these genes affect mood and endogenous pain modulation, both demonstrated to be altered in fibromyalgia subjects (FMS). Here, we tested the effects of genetic variants of the 5‐HT1A receptor (CC/G-carriers) and 5-HTT (high/intermediate/low expression) on mood, pain sensitivity, cerebral processing of evoked pain (functional MRI) and concentrations of GABA and glutamate (MR spectroscopy) in rostral anterior cingulate cortex (rACC) and thalamus in FMS and healthy controls (HC). Interactions between serotonin-relevant genes were found in affective characteristics, with genetically inferred high serotonergic signalling (5-HT1A CC/5-HTThigh genotypes) being more favourable across groups. Additionally, 5‐HT1A CC homozygotes displayed higher pain thresholds than G-carriers in HC but not in FMS. Cerebral processing of evoked pressure pain differed between groups in thalamus with HC showing more deactivation than FMS, but was not influenced by serotonin-relevant genotypes. In thalamus, we observed a 5‐HT1A-by-5-HTT and group-by-5-HTT interaction in GABA concentrations, with the 5-HTT high expressing genotype differing between groups and 5‐HT1A genotypes. No significant effects were seen for glutamate or in rACC. To our knowledge, this is the first report of this serotonergic gene-to-gene interaction associated with mood, both among FMS (depression) and across groups (anxiety). Additionally, our findings provide evidence of an association between the serotonergic system and thalamic GABA concentrations, with individuals possessing genetically inferred high serotonergic signalling exhibiting the highest GABA concentrations, possibly enhancing GABAergic inhibitory effects via 5-HT.

Files

13041_2021_789_MOESM3_ESM.pdf

Files (1.4 MB)

Name Size Download all
md5:5c4c90eaa048e7ca027cabeeceaa5db7
24.9 kB Download
md5:dc92c68c5138a51aa727bda22c6c73e0
35.6 kB Download
md5:6f98ff604d0c5a79b4a8cdc82a63c75a
23.3 kB Preview Download
md5:56f637d21ac1c373c0416211a8282cda
39.6 kB Preview Download
md5:cef724f4c9e75d44bbdd659af54d3adc
1.2 MB Preview Download
md5:1d727aed78a01b94d8640a2a06dd4625
18.2 kB Download

Additional details

Funding

GLORIA – Understanding chronic pain and new druggable targets: Focus on glial-opioid receptor interface 602919
European Commission